Luis C. Pena insider trades: Evommune (EVMN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Luis reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | EVMN | ↓ Sell | 7,438 | $22.71 | $169K | Direct | Jun 24, 2026 (2d) |
| Jun 1, 2026 | EVMN | ↓ Sell | 16,787 | $22.74 | $382K | Direct | Jun 3, 2026 (2d) |
| Aug 19, 2019 | DERM | ↓ Sell | 23,419 | $8.54 | $200K | Direct | Aug 19, 2019 (0d) |
| Jun 23, 2016 | DERM | ↓ Sell | 10,000 | $30.01 | $300K | Direct | Jun 24, 2016 (1d) |
| Jun 15, 2016 | DERM | ↓ Sell | 10,000 | $29.47 | $295K | Direct | Jun 17, 2016 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EVMN insiders
Open-market trades in the last 12 months
About Luis C. Pena's insider trades
Luis C. Pena is President & CEO at Evommune (EVMN). Since Jun 15, 2016, Luis has reported no open-market purchases and 5 sales worth $1.3M on SEC Form 4. In the last 12 months: 2 sales ($551K).
Their filings also include grants and awards (8 filings), option exercises (8 filings), shares withheld for taxes (6 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EVMN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.